Gene · 2046
Papers2,828
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,828
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deletion and replacement of long genomic sequences using prime editing. | Nat Biotechnol | 2022 | 34650270 | PubTator, text mining | PubMed |
| Engineered pegRNAs improve prime editing efficiency. | Nat Biotechnol | 2022 | 34608327 | PubTator, text mining | PubMed |
| Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin. | Cancer Gene Ther | 2022 | 34426652 | PubTator, text mining | PubMed |
| Design and stability of pediatric oral formulation of imatinib. | J Oncol Pharm Pract | 2022 | 33522386 | PubTator, text mining | PubMed |
If Artificial In Vitro Microenvironment Can Influence Tumor Drug Resistance Network via Modulation of lncRNA Expression?-Comparative Analysis of Glioblastoma-Derived Cell Culture Models and Initial Tumors In Vivo. | Cell Mol Neurobiol | 2022 | 33245508 | PubTator, text mining | PubMed |
| Glycemic variability: Importance, relationship with physical activity, and the influence of exercise. | Sports Med Health Sci | 2021 | 35783368 | PubTator, text mining | PubMed |
| Identifying Actionable Variants Using Capture-Based Targeted Sequencing in 563 Patients With Non-Small Cell Lung Carcinoma. | Front Oncol | 2021 | 35186718 | PubTator, text mining | PubMed |
| Role of EGF Receptor Regulatory Networks in the Host Response to Viral Infections. | Front Cell Infect Microbiol | 2021 | 35083168 | PubTator, text mining | PubMed |
| Extracellular Vesicles as a New Promising Therapy in HIV Infection. | Front Immunol | 2021 | 35058938 | PubTator, text mining | PubMed |
| A Pilot Study on Early-Onset Schizophrenia Reveals the Implication of Wnt, Cadherin and Cholecystokinin Receptor Signaling in Its Pathophysiology. | Front Genet | 2021 | 34976023 | PubTator, text mining | PubMed |
| SHED-Dependent Oncogenic Signaling of the PEAK3 Pseudo-Kinase. | Cancers (Basel) | 2021 | 34944965 | PubTator, text mining | PubMed |
| Genome-Wide RNAi Screening Identifies Novel Pathways/Genes Involved in Oxidative Stress and Repurposable Drugs to Preserve Cystic Fibrosis Airway Epithelial Cell Integrity. | Antioxidants (Basel) | 2021 | 34943039 | PubTator, text mining | PubMed |
| Targeting RAS phosphorylation in cancer therapy: Mechanisms and modulators. | Acta Pharm Sin B | 2021 | 34900528 | PubTator, text mining | PubMed |
The Preventive Effect of Cardiac Sympathetic Denervation Induced by 6-OHDA on Myocardial Ischemia-Reperfusion Injury: The Changes of lncRNA/circRNAs-miRNA-mRNA Network of the Upper Thoracic Spinal Cord in Rats. | Oxid Med Cell Longev | 2021 | 34880964 | PubTator, text mining | PubMed |
| Generic Anticancer Drugs of the Jan Aushadhi Scheme in India and Their Branded Counterparts: The First Cost Comparison Study. | Cureus | 2021 | 34877208 | PubTator, text mining | PubMed |
| Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma. | Front Oncol | 2021 | 34868980 | PubTator, text mining | PubMed |
Effects of core stabilization exercise and strengthening exercise on proprioception, balance, muscle thickness and pain related outcomes in patients with subacute nonspecific low back pain: a randomized controlled trial. | BMC Musculoskelet Disord | 2021 | 34847915 | PubTator, text mining | PubMed |
| Uncovering the action mechanism of homoharringtonine against colorectal cancer by using network pharmacology and experimental evaluation. | Bioengineered | 2021 | 34847838 | PubTator, text mining | PubMed |
| Multiple Myeloma Cell-Derived Exosomes: Implications on Tumorigenesis, Diagnosis, Prognosis and Therapeutic Strategies. | Cells | 2021 | 34831088 | PubTator, text mining | PubMed |
| RHAMMB-mediated bifunctional nanotherapy targeting Bcl-xL and mitochondria for pancreatic neuroendocrine tumor treatment. | Mol Ther Oncolytics | 2021 | 34761107 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2046/papers?page=20